Subclinical Left Ventricular Dysfunction in Children and Adolescence With Thalassemia Intermedia

Roya Isa Tafreshi1, Mohammad Radgoodarzi2, Kadijeh Arjmandi Rafsanjani3

  • 1Department of Pediatric Cardiology, Ali Asghar Children's Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Insights

Early cardiac dysfunction is detectable in children with thalassemia intermedia (TI) using advanced echocardiography. Tissue Doppler imaging (TDI) reveals subtle left ventricular (LV) systolic and diastolic impairments, even without high iron levels.

Area of Science:

  • Cardiology
  • Pediatrics
  • Medical Imaging

Background:

  • Thalassemia intermedia (TI) is associated with significant cardiac morbidity.
  • Early detection of cardiac complications is crucial for managing TI patients.
  • Left ventricular (LV) dysfunction can occur even in asymptomatic individuals.

Purpose of the Study:

  • To assess left ventricular (LV) function in asymptomatic children and adolescents with TI.
  • To utilize novel tissue Doppler imaging (TDI) indices for early diagnosis of ventricular impairment.
  • To identify early systolic and diastolic dysfunction in TI patients.

Main Methods:

  • Compared echocardiographic parameters in 28 asymptomatic TI patients and 35 healthy controls.
  • Utilized 2-D, pulsed Doppler, and TDI for LV mass, mitral inflow, and annular velocities.
  • Assessed myocardial performance index (MPI) and myocardial acceleration during isovolumic contraction (IVA).
  • Estimated cardiac iron load using magnetic resonance imaging T2*.

Main Results:

  • Left ventricular hypertrophy (LVH) present in 46.4% of TI patients.
  • Reduced TDI-derived peak systolic myocardial velocity (s') observed in TI patients.
  • Elevated E/e' ratio, an index of diastolic function, in TI patients (9 ± 1 vs. 6 ± 1, p < 0.05).
  • TDI-derived MPI > 0.33 detected global LV dysfunction with 78% sensitivity and 80% specificity.
  • Patients with LVH showed higher TDI-MPI and lower s' and IVA values.

Conclusions:

  • Subtle LV systolic and diastolic dysfunction occurs early in young TI patients, independent of iron concentration.
  • LV remodeling is a key adaptive response contributing to myocardial impairment in TI.
  • TDI indices are valuable for early detection of cardiac dysfunction in pediatric TI.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
43
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
32
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
30
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
20
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
49
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
23